USD 0.06
(-39.94%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 200 Thousand USD | 0.0% |
2022 | 200 Thousand USD | 0.0% |
2021 | 200 Thousand USD | -42.49% |
2020 | 347.75 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 100 Thousand USD | 0.0% |
2014 | - USD | -100.0% |
2013 | 60 Thousand USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | 0.0% |
1995 | - USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
1991 | - USD | -100.0% |
1990 | 250 Thousand USD | -10.71% |
1989 | 280 Thousand USD | -67.44% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q2 | - USD | -100.0% |
2023 FY | 200 Thousand USD | 0.0% |
2023 Q1 | 200 Thousand USD | 0.0% |
2022 Q4 | 200 Thousand USD | 0.0% |
2022 FY | 200 Thousand USD | 0.0% |
2022 Q1 | 200 Thousand USD | 0.0% |
2022 Q2 | - USD | -100.0% |
2022 Q3 | - USD | 0.0% |
2021 Q4 | 200 Thousand USD | -71.28% |
2021 Q1 | 346.99 Thousand USD | -0.22% |
2021 FY | 200 Thousand USD | -42.49% |
2021 Q2 | 345.54 Thousand USD | -0.42% |
2021 Q3 | 696.34 Thousand USD | 101.52% |
2020 Q2 | 350 Thousand USD | 0.0% |
2020 FY | 347.75 Thousand USD | 0.0% |
2020 Q4 | 347.75 Thousand USD | -0.64% |
2020 Q1 | - USD | 0.0% |
2020 Q3 | 350 Thousand USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | -100.0% |
2016 FY | - USD | -100.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 FY | 100 Thousand USD | 0.0% |
2015 Q2 | 100 Thousand USD | 0.0% |
2015 Q1 | 100 Thousand USD | 0.0% |
2015 Q3 | 100 Thousand USD | 0.0% |
2015 Q4 | 100 Thousand USD | 0.0% |
2014 Q1 | 900.57 Thousand USD | 5120.74% |
2014 Q3 | 1.51 Million USD | -1.13% |
2014 FY | - USD | -100.0% |
2014 Q4 | - USD | -100.0% |
2014 Q2 | 1.52 Million USD | 69.81% |
2013 Q3 | 17.25 Thousand USD | -18.25% |
2013 FY | 60 Thousand USD | 0.0% |
2013 Q1 | 15.25 Thousand USD | 0.0% |
2013 Q2 | 21.1 Thousand USD | 38.36% |
2013 Q4 | 17.25 Thousand USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 Q2 | - USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1996 Q3 | - USD | 0.0% |
1996 Q4 | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1996 Q1 | - USD | 0.0% |
1996 Q2 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1995 Q4 | - USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1993 Q1 | - USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1992 FY | - USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1991 Q2 | 190 Thousand USD | -17.39% |
1991 Q1 | 230 Thousand USD | -4.17% |
1991 FY | - USD | -100.0% |
1991 Q3 | - USD | -100.0% |
1990 Q1 | 300 Thousand USD | 0.0% |
1990 FY | 250 Thousand USD | -10.71% |
1990 Q4 | 240 Thousand USD | -4.0% |
1990 Q3 | 250 Thousand USD | -7.41% |
1990 Q2 | 270 Thousand USD | -10.0% |
1989 Q3 | 280 Thousand USD | 21.74% |
1989 FY | 280 Thousand USD | -67.44% |
1989 Q4 | 300 Thousand USD | 7.14% |
1989 Q2 | 230 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Avitar, Inc. | 3.89 Million USD | 94.867% |
BioElectronics Corporation | 12.52 Million USD | 98.404% |
CVR Medical Corp. | - USD | -Infinity% |
IR-Med Inc. | 161 Thousand USD | -24.224% |
Medical Supply International USA, Inc. | 116.05 Thousand USD | -72.334% |
Polarean Imaging plc | 74.84 Thousand USD | -167.215% |
AVITA Medical, Inc. | 449.48 Thousand USD | 55.504% |
Manhattan Scientifics, Inc. | - USD | -Infinity% |
Össur hf. | 311.8 Million USD | 99.936% |
Zecotek Photonics Inc. | - USD | -Infinity% |
QHSLab, Inc. | - USD | -Infinity% |
Wellstar International, Inc. | 18.86 Million USD | 98.94% |
Össur hf. | 311.8 Million USD | 99.936% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 618 Thousand USD | 67.638% |
Escalon Medical Corp. | 279.4 Thousand USD | 28.419% |
Aurora Spine Corporation | 1.59 Million USD | 87.436% |
BrainsWay Ltd. | 239 Thousand USD | 16.318% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | - USD | -Infinity% |
Hamilton Thorne Ltd. | 16.7 Million USD | 98.803% |
Vivos Inc. | - USD | -Infinity% |
MicroPort Scientific Corporation | 814.21 Million USD | 99.975% |
Kelyniam Global, Inc. | 217.61 Thousand USD | 8.093% |
REMSleep Holdings, Inc. | 43.67 Thousand USD | -357.917% |
CYduct Diagnostics, Inc. | 590 Thousand USD | 66.102% |
Nanomix Corporation | 10.11 Million USD | 98.022% |
Theraclion SA | 1.95 Million EUR | 89.747% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 304.6 Thousand USD | 34.34% |
Positron Corporation | - USD | -Infinity% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 150 Thousand USD | -33.333% |
Lombard Medical, Inc. | 28.02 Million USD | 99.286% |
ALR Technologies Inc. | - USD | -Infinity% |
Stratec SE | 89.25 Million USD | 99.776% |
Vycor Medical, Inc. | 243.28 Thousand USD | 17.793% |
Heart Tronics, Inc. | - USD | -Infinity% |
Nu-Med Plus, Inc. | - USD | -Infinity% |
Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -40.52% |
SANUWAVE Health, Inc. | 492 Thousand USD | 59.35% |
VMS Rehab Systems, Inc. | 106.45 USD | -187781.635% |
Guided Therapeutics, Inc. | 511 Thousand USD | 60.861% |
Ingen Technologies, Inc. | 532.27 Thousand USD | 62.426% |
Odyssey Group International, Inc. | - USD | -Infinity% |
United American Healthcare Corporation | - USD | -Infinity% |
ECGI Holdings, Inc. | 804 Thousand USD | 75.124% |
Capital Group Holdings, Inc. | - USD | -Infinity% |
ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 37.966% |
Urologix, Inc. | 4.58 Million USD | 95.639% |
Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 53.514% |
Nexeon MedSystems Inc. | 2.78 Million USD | 92.822% |
SS Innovations International, Inc. | 1.91 Million USD | 89.531% |
Qualis Innovations, Inc. | - USD | -Infinity% |
Smith & Nephew plc | 2.17 Billion USD | 99.991% |
NIOX Group Plc | 500 Thousand USD | 60.0% |
Broncus Holding Corporation | 1.22 Million USD | 83.66% |
Brain Scientific Inc. | 7378.00 USD | -2610.762% |
Pressure BioSciences, Inc. | 161.86 Thousand USD | -23.561% |
Health Logic Interactive Inc. | - USD | -Infinity% |